PlainRecalls
FDA Devices Moderate Class II Terminated

BG3515-5 US 5mL BioGlue Surgical Adhesive. BioGlue Surgical Adhesive (BioGlue) is indicated for use as an adjunct to standard methods of achieving hemostasis (such as sutures and staples) in adult patients in open surgical repair of of large vessels (such as aorta, femoral, and carotid arteries).

Reported: June 11, 2014 Initiated: April 25, 2014 #Z-1674-2014

Product Description

BG3515-5 US 5mL BioGlue Surgical Adhesive. BioGlue Surgical Adhesive (BioGlue) is indicated for use as an adjunct to standard methods of achieving hemostasis (such as sutures and staples) in adult patients in open surgical repair of of large vessels (such as aorta, femoral, and carotid arteries).

Reason for Recall

Serum albumin component monomer failed to meet internally established end of shelf-life specification.

Details

Recalling Firm
CryoLife, Inc.
Units Affected
6190 units
Distribution
Distributed Nationwide including Puerto Rico and the states of AL, AK,AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, MT, NV, NH, NJ, NM , NY, NC, ND, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV, and WI.
Location
Kennesaw, GA

Frequently Asked Questions

What product was recalled?
BG3515-5 US 5mL BioGlue Surgical Adhesive. BioGlue Surgical Adhesive (BioGlue) is indicated for use as an adjunct to standard methods of achieving hemostasis (such as sutures and staples) in adult patients in open surgical repair of of large vessels (such as aorta, femoral, and carotid arteries).. Recalled by CryoLife, Inc.. Units affected: 6190 units.
Why was this product recalled?
Serum albumin component monomer failed to meet internally established end of shelf-life specification.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 11, 2014. Severity: Moderate. Recall number: Z-1674-2014.